Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01864642 · ClinicalTrials.gov registry record · NA

Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects

A NA study of Glaucoma and Ocular Hypertension, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT01864642 is a NA study of Glaucoma and Ocular Hypertension that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 28 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01864642, a NA study of Glaucoma and Ocular Hypertension, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The hypothesis is that osteopathic manipulative treatment (OMT)will significantly reduce intraocular pressure (IOP) in individuals with ocular hypertension (OHT) and glaucoma suspect patients.

Interventions

  • PROCEDURE osteopathic manipulative treatment (OMT)

Study Locations (1)

Wisconsin

  • UW Dept of Ophthalmology Clinic - Madison

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2013-07
Est. Completion 2014-06
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT01864642

The ClinicalTrials.gov registry entry for NCT01864642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which osteopathic manipulative treatment (OMT) is the first listed.

NCT01864642 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01864642 about?

NCT01864642 is a clinical study titled "Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects". The hypothesis is that osteopathic manipulative treatment (OMT)will significantly reduce intraocular pressure (IOP) in individuals with ocular hypertension (OHT) and glaucoma suspect patients.

What is the current status of trial NCT01864642?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2013-07. Estimated completion is 2014-06.

What conditions does trial NCT01864642 study?

This clinical trial studies the following conditions: Glaucoma, Ocular Hypertension.

What interventions are being tested in trial NCT01864642?

The interventions under investigation include: osteopathic manipulative treatment (OMT) (PROCEDURE).

Who is sponsoring clinical trial NCT01864642?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01864642 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.